{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Entera Bio Ltd. technically bullish or bearish?
As of June 17, 2025, the trend has shifted to mildly bullish due to positive monthly MACD and moving averages, but caution is advised due to mixed signals from the weekly MACD and KST.
Who are in the management team of Entera Bio Ltd.?
As of March 2022, the management team of Entera Bio Ltd. includes Mr. Gerald Lieberman (Independent Chairman), Dr. Spiros Jamas (CEO), and directors Mr. Zeev Bronfeld, Mr. Sean Ellis, Mr. Yonatan Malca, Ms. Faith Charles, and Mr. Gerald Ostrov. They oversee the company's strategic direction and operations.
What does Entera Bio Ltd. do?
Entera Bio Ltd. is an Israel-based biotechnology company specializing in the oral delivery of large molecules and biologics. It has a market cap of $95 million and reported a net loss of $3 million in its most recent quarter.
How big is Entera Bio Ltd.?
As of Jun 18, Entera Bio Ltd. has a market capitalization of 95.00 million, with net sales of 0.22 million and a net profit of -10.10 million over the last four quarters. The company reported shareholder's funds of 8.08 million and total assets of 9.39 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
